These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31268657)

  • 1. Dual-Targeted Lactoferrin Shell-Oily Core Nanocapsules for Synergistic Targeted/Herbal Therapy of Hepatocellular Carcinoma.
    Abdelmoneem MA; Elnaggar MA; Hammady RS; Kamel SM; Helmy MW; Abdulkader MA; Zaky A; Fang JY; Elkhodairy KA; Elzoghby AO
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26731-26744. PubMed ID: 31268657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-targeted casein micelles as green nanomedicine for synergistic phytotherapy of hepatocellular carcinoma.
    Abdelmoneem MA; Mahmoud M; Zaky A; Helmy MW; Sallam M; Fang JY; Elkhodairy KA; Elzoghby AO
    J Control Release; 2018 Oct; 287():78-93. PubMed ID: 30138716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma.
    Wei M; Guo X; Tu L; Zou Q; Li Q; Tang C; Chen B; Xu Y; Wu C
    Int J Nanomedicine; 2015; 10():5123-37. PubMed ID: 26316745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decorating protein nanospheres with lactoferrin enhances oral COX-2 inhibitor/herbal therapy of hepatocellular carcinoma.
    Abdelmoneem MA; Mahmoud M; Zaky A; Helmy MW; Sallam M; Fang JY; Elkhodairy KA; Elzoghby AO
    Nanomedicine (Lond); 2018 Oct; 13(19):2377-2395. PubMed ID: 30346255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic/lactobionic acid dual-targeted polymeric nanocapsules for potential treatment of hepatocellular carcinoma.
    Kabil MF; Gaber SAA; Hamzawy MA; El-Sherbiny IM; Nasr M
    Drug Deliv Transl Res; 2024 May; 14(5):1338-1351. PubMed ID: 37930630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobionic/Folate Dual-Targeted Amphiphilic Maltodextrin-Based Micelles for Targeted Codelivery of Sulfasalazine and Resveratrol to Hepatocellular Carcinoma.
    Anwar DM; Khattab SN; Helmy MW; Kamal MK; Bekhit AA; Elkhodairy KA; Elzoghby AO
    Bioconjug Chem; 2018 Sep; 29(9):3026-3041. PubMed ID: 30110148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boronic-targeted albumin-shell oily-core nanocapsules for synergistic aromatase inhibitor/herbal breast cancer therapy.
    Gaber M; Hany M; Mokhtar S; Helmy MW; Elkodairy KA; Elzoghby AO
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110099. PubMed ID: 31546395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication of Imatinib Mesylate-Loaded Lactoferrin-Modified PEGylated Liquid Crystalline Nanoparticles for Mitochondrial-Dependent Apoptosis in Hepatocellular Carcinoma.
    Nisha R; Kumar P; Kumar U; Mishra N; Maurya P; Singh S; Singh P; Guleria A; Saha S; Saraf SA
    Mol Pharm; 2021 Mar; 18(3):1102-1120. PubMed ID: 33356314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactoferrin-tagged quantum dots-based theranostic nanocapsules for combined COX-2 inhibitor/herbal therapy of breast cancer.
    AbdElhamid AS; Zayed DG; Helmy MW; Ebrahim SM; Bahey-El-Din M; Zein-El-Dein EA; El-Gizawy SA; Elzoghby AO
    Nanomedicine (Lond); 2018 Oct; 13(20):2637-2656. PubMed ID: 30338705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA.
    Chen F; Zhang J; He Y; Fang X; Wang Y; Chen M
    Biomater Sci; 2016 Jan; 4(1):167-82. PubMed ID: 26484363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel lactoferrin-modified stealth liposome for hepatoma-delivery of triiodothyronine.
    Pireddu R; Pibiri M; Valenti D; Sinico C; Fadda AM; Simbula G; Lai F
    Int J Pharm; 2018 Feb; 537(1-2):257-267. PubMed ID: 29294323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-Ligand Functionalized Core-Shell Chitosan-Based Nanocarrier for Hepatocellular Carcinoma-Targeted Drug Delivery.
    Hefnawy A; Khalil IH; Arafa K; Emara M; El-Sherbiny IM
    Int J Nanomedicine; 2020; 15():821-837. PubMed ID: 32103939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer.
    Yang T; Lan Y; Cao M; Ma X; Cao A; Sun Y; Yang J; Li L; Liu Y
    Colloids Surf B Biointerfaces; 2019 Mar; 175():106-115. PubMed ID: 30529816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro targeting effect of lactoferrin modified PEGylated liposomes for hepatoma cells].
    Wei MY; Zou Q; Wu CB; Xu YH
    Yao Xue Xue Bao; 2015 Oct; 50(10):1272-9. PubMed ID: 26837173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
    Zhao L; Liang L; Guo M; Li M; Yu X; Wang Y; Wang Y
    Curr Top Med Chem; 2021 Oct; 21(14):1268-1284. PubMed ID: 34620053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of camptothecin and MiR-145 by lipid nanoparticles for MRI-visible targeted therapy of hepatocellular carcinoma.
    Rong J; Liu T; Yin X; Shao M; Zhu K; Li B; Wang S; Zhu Y; Zhang S; Yin L; Liu Q; Wang X; Zhang L
    J Exp Clin Cancer Res; 2024 Aug; 43(1):247. PubMed ID: 39215325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic core-shell nanocapsules with dual-targeting capabilities and co-delivery of multiple drugs to treat brain gliomas.
    Fang JH; Lai YH; Chiu TL; Chen YY; Hu SH; Chen SY
    Adv Healthc Mater; 2014 Aug; 3(8):1250-60. PubMed ID: 24623647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.
    Zhang J; Zhang M; Ji J; Fang X; Pan X; Wang Y; Wu C; Chen M
    Pharm Res; 2015 Oct; 32(10):3376-90. PubMed ID: 26148773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
    Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
    Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of encapsulated bovine lactoferrin protein nanocapsules against intracellular parasite Toxoplasma gondii.
    Anand N; Sehgal R; Kanwar RK; Dubey ML; Vasishta RK; Kanwar JR
    Int J Nanomedicine; 2015; 10():6355-69. PubMed ID: 26504384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.